Three‐year Open Protocol Continuation Study of Oral Tolerization with Myelin Antigens in Multiple Sclerosis and Design of a Phase III Pivotal Trial
- 1 February 1996
- journal article
- clinical trial
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 778 (1), 243-250
- https://doi.org/10.1111/j.1749-6632.1996.tb21132.x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Antigen‐specific TGF‐β1 Secretion with Bovine Myelin Oral Tolerization in Multiple SclerosisAnnals of the New York Academy of Sciences, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Interferon beta‐lb in the treatment of multiple sclerosisNeurology, 1995
- Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple SclerosisScience, 1993
- Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the lewis rat and strain 13 guinea pigAnnals of Neurology, 1991
- Overview of the Mucosal Immune SystemPublished by Springer Nature ,1989
- Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic proteinCellular Immunology, 1988
- Immunotherapy of multiple sclerosisAnnals of Neurology, 1988
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Studies on the Chemistry of Anaphylaxis (III). Experiments with Isolated Proteins, Especially those of the Hen's EggThe Journal of Infectious Diseases, 1911